REFERENCES
1. Pan D, Nazareth J, Sze S, et al. Transmission of monkeypox/mpox
virus: A narrative review of environmental, viral, host, and population
factors in relation to the 2022 international outbreak. Journal of
Medical Virology . 2023;95(2):e28534.
2. Kumar N, Tripathi BN. A serious skin virus epidemic sweeping through
the Indian subcontinent is a threat to the livelihood of farmers.Virulence . Dec 2022;13(1):1943-1944.
doi:10.1080/21505594.2022.2141971
3. Haller SL, Peng C, McFadden G, Rothenburg S. Poxviruses and the
evolution of host range and virulence. Infection, genetics and
evolution : journal of molecular epidemiology and evolutionary genetics
in infectious diseases . Jan 2014;21:15-40.
doi:10.1016/j.meegid.2013.10.014
4. Bera BC, Shanmugasundaram K, Barua S, et al. Zoonotic cases of
camelpox infection in India. Veterinary microbiology . Aug 26
2011;152(1-2):29-38. doi:10.1016/j.vetmic.2011.04.010
5. Marinaik CB, Venkatesha MD, Gomes AR, Reddy P, Nandini P, Byregowda
SM. Isolation and molecular characterization of zoonotic Buffalopox
virus from skin lesions of humans in India. International journal
of dermatology . May 2018;57(5):590-592. doi:10.1111/ijd.13890
6. Patil DY, George S, Sahay RR, et al. A case of human buffalopox in
Malappuram, India: The role of mpox surveillance in 2022. Journal
of Medical Virology . 2023;95(2):e28580.
7. Alakunle EF, Okeke MI. Monkeypox virus: a neglected zoonotic pathogen
spreads globally. Nature reviews Microbiology . Sep
2022;20(9):507-508. doi:10.1038/s41579-022-00776-z
8. Caillat C, Topalis D, Agrofoglio LA, et al. Crystal structure of
poxvirus thymidylate kinase: an unexpected dimerization has implications
for antiviral therapy. Proceedings of the National Academy of
Sciences of the United States of America . Nov 4 2008;105(44):16900-5.
doi:10.1073/pnas.0804525105
9. Yang H, Kim SK, Kim M, et al. Antiviral chemotherapy facilitates
control of poxvirus infections through inhibition of cellular signal
transduction. The Journal of clinical investigation . Feb
2005;115(2):379-87. doi:10.1172/JCI23220
10. Junge RE, Duncan MC, Miller RE, Gregg D, Kombert M. Clinical
presentation and antiviral therapy for poxvirus infection in pudu (Pudu
puda). Journal of zoo and wildlife medicine : official publication
of the American Association of Zoo Veterinarians . Sep 2000;31(3):412-8.
doi:10.1638/1042-7260(2000)031[0412:CPAATF]2.0.CO;2
11. De Clercq E. Vaccinia virus inhibitors as a paradigm for the
chemotherapy of poxvirus infections. Clinical microbiology
reviews . Apr 2001;14(2):382-97. doi:10.1128/CMR.14.2.382-397.2001
12. Neyts J, De Clercq E. Efficacy of
2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purine for treatment of
vaccinia virus (orthopoxvirus) infections in mice. Antimicrobial
agents and chemotherapy . Jan 2001;45(1):84-7.
doi:10.1128/AAC.45.1.84-87.2001
13. Snoeck R, De Clercq E. Role of cidofovir in the treatment of DNA
virus infections, other than CMV infections, in immunocompromised
patients. Current opinion in investigational drugs . Nov
2002;3(11):1561-6.
14. Grosenbach DW, Honeychurch K, Rose EA, et al. Oral Tecovirimat for
the Treatment of Smallpox. The New England journal of medicine .
Jul 5 2018;379(1):44-53. doi:10.1056/NEJMoa1705688
15. Broekema FI, Dikkers FG. Side-effects of cidofovir in the treatment
of recurrent respiratory papillomatosis. European archives of
oto-rhino-laryngology : official journal of the European Federation of
Oto-Rhino-Laryngological Societies . Aug 2008;265(8):871-9.
doi:10.1007/s00405-008-0658-0
16. Romanowski EG, Gordon YJ, Araullo-Cruz T, Yates KA, Kinchington PR.
The antiviral resistance and replication of cidofovir-resistant
adenovirus variants in the New Zealand White rabbit ocular model.Investigative ophthalmology & visual science . Jul
2001;42(8):1812-5.
17. Chen F, Chu C, Wang X, et al. Hesperetin attenuates sepsis-induced
intestinal barrier injury by regulating neutrophil extracellular trap
formation via the ROS/autophagy signaling pathway. Food &
function . May 11 2023;14(9):4213-4227. doi:10.1039/d2fo02707k
18. Zaafar D, Khalil HMA, Rasheed RA, Eltelbany RFA, Zaitone SA.
Hesperetin mitigates sorafenib-induced cardiotoxicity in mice through
inhibition of the TLR4/NLRP3 signaling pathway. PloS one .
2022;17(8):e0271631. doi:10.1371/journal.pone.0271631
19. Kong LN, Lin X, Huang C, et al. Hesperetin derivative-12 (HDND-12)
regulates macrophage polarization by modulating JAK2/STAT3 signaling
pathway. Chinese journal of natural medicines . Feb
2019;17(2):122-130. doi:10.1016/S1875-5364(19)30014-7
20. Fatriansyah JF, Rizqillah RK, Yandi MY. Molecular Docking and
Molecular Dynamics Simulation of Fisetin, Galangin, Hesperetin,
Hesperidin, Myricetin, and Naringenin against Polymerase of Dengue
Virus. Journal of tropical medicine . 2022;2022:7254990.
doi:10.1155/2022/7254990
21. Eberle RJ, Olivier DS, Pacca CC, et al. In vitro study of Hesperetin
and Hesperidin as inhibitors of zika and chikungunya virus proteases.PloS one . 2021;16(3):e0246319. doi:10.1371/journal.pone.0246319
22. Paredes A, Alzuru M, Mendez J, Rodriguez-Ortega M. Anti-Sindbis
activity of flavanones hesperetin and naringenin. Biological &
pharmaceutical bulletin . Jan 2003;26(1):108-9. doi:10.1248/bpb.26.108
23. Kumar N, Chander Y, Kumar R, et al. Isolation and characterization
of lumpy skin disease virus from cattle in India. PloS one .
2021;16(1):e0241022. doi:10.1371/journal.pone.0241022
24. Khandelwal N, Chander Y, Kumar R, et al. Antiviral activity of
Apigenin against buffalopox: Novel mechanistic insights and
drug-resistance considerations. Antiviral research . Sep
2020;181:104870. doi:10.1016/j.antiviral.2020.104870
25. Chander Y, Kumar R, Verma A, et al. Resistance Evolution against
Host-directed Antiviral Agents: Buffalopox Virus Switches to Use
p38-Upsilon under Long-term Selective Pressure of an Inhibitor Targeting
p38-alpha. Molecular biology and evolution . Sep 1
2022;39(9)doi:10.1093/molbev/msac177
26. Khandelwal N, Chander Y, Rawat KD, et al. Emetine inhibits
replication of RNA and DNA viruses without generating drug-resistant
virus variants. Antiviral Research . 2017;144:196-204.
27. Khandelwal N, Chander Y, Kumar R, et al. Antiviral activity of
Apigenin against buffalopox: Novel mechanistic insights and
drug-resistance considerations. Antiviral Research .
2020;181:104870.
28. Chander Y, Kumar R, Verma A, et al. Resistance evolution against
host-directed antiviral agents: Buffalopox virus switches to use p38-ϒ
under long-term selective pressure of an inhibitor targeting p38-α.Molecular Biology and Evolution . 2022;
29. Biasini M, Bienert S, Waterhouse A, et al. SWISS-MODEL: modelling
protein tertiary and quaternary structure using evolutionary
information. Nucleic acids research . 2014;42(W1):W252-W258.
30. Maier JA, Martinez C, Kasavajhala K, Wickstrom L, Hauser KE,
Simmerling C. ff14SB: improving the accuracy of protein side chain and
backbone parameters from ff99SB. Journal of chemical theory and
computation . 2015;11(8):3696-3713.
31. Kumar R, Afsar M, Khandelwal N, et al. Emetine suppresses SARS-CoV-2
replication by inhibiting interaction of viral mRNA with eIF4E.Antiviral research . 2021;189:105056.
32. Eberhardt J, Santos-Martins D, Tillack AF, Forli S. AutoDock Vina
1.2. 0: New docking methods, expanded force field, and python bindings.Journal of chemical information and modeling .
2021;61(8):3891-3898.
33. Wallace AC, Laskowski RA, Thornton JM. LIGPLOT: a program to
generate schematic diagrams of protein-ligand interactions.Protein engineering, design and selection . 1995;8(2):127-134.
34. López-Blanco JR, Aliaga JI, Quintana-Ortí ES, Chacón P. iMODS:
internal coordinates normal mode analysis server. Nucleic acids
research . 2014;42(W1):W271-W276.
35. Kumar R, Khandelwal N, Thachamvally R, et al. Role of MAPK/MNK1
signaling in virus replication. Virus research . Jul 15
2018;253:48-61. doi:10.1016/j.virusres.2018.05.028
36. Siddiqui N, Tempel W, Nedyalkova L, et al. Structural insights into
the allosteric effects of 4EBP1 on the eukaryotic translation initiation
factor eIF4E. Journal of molecular biology . 2012;415(5):781-792.
37. Tomoo K, Shen X, Okabe K, et al. Crystal structures of
7-methylguanosine 5′-triphosphate (m7GTP)-and
P1-7-methylguanosine-P3-adenosine-5′, 5′-triphosphate (m7GpppA)-bound
human full-length eukaryotic initiation factor 4E: biological importance
of the C-terminal flexible region. Biochemical Journal .
2002;362(3):539-544.
38. Marennikova S, Shelukhina E, Shenkman L. Role of the temperature of
incubation of infected chick embryos in the differentiation of certain
poxviruses according to pock morphology. Acta Virologica .
1973;17(4)
39. Baxby D. Variability in the characteristics of pocks produced on the
chick chorioallantois by white pock mutants of cowpox and other
poxviruses. Epidemiology & Infection . 1969;67(4):637-647.
40. Ding P, Summers MF. Sequestering the 5’-cap for viral RNA packaging.BioEssays : news and reviews in molecular, cellular and
developmental biology . Nov 2022;44(11):e2200104.
doi:10.1002/bies.202200104
41. Kumar R, Khandelwal N, Chander Y, et al. MNK1 inhibitor as an
antiviral agent suppresses buffalopox virus protein synthesis.Antiviral research . Dec 2018;160:126-136.
doi:10.1016/j.antiviral.2018.10.022
42. Donaldson EF, Deming DJ, O’Rear JJ, Naeger LK. Regulatory evaluation
of antiviral drug resistance in the era of next-generation sequencing.Biomarkers in medicine . 2015;9(11):1047-51. doi:10.2217/bmm.15.63